Danni He
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Danni He has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Qi Zhang
Department of Pediatrics, China-Japan Friendship Hospital, Beijing, China
2 shared publications - Bin Zhou
Key Laboratory of Animal Microbiology of China’s Ministry of Agriculture, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China
1 shared publication Fan Li
1 shared publicationHengmei Shi
Department of Obstetrics and Gynecology, Women’s Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing, Jiangsu, China
1 shared publicationHuyang Hou
Department of Obstetrics and Gynecology, Women’s Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing, Jiangsu, China
1 shared publication- Jiaheng Xie
Department of Plastic Surgery, Xiangya Hospital Central South University, Changsha, China.
1 shared publication
Latest Publications
- Open Access
- 1 December 2025
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 18, 18151-18163
Plasma Bile Acid Profiling Reveals Novel Early Diagnostic Biomarkers for Pediatric Sepsis
Sepsis is a life-threatening condition, and early detection remains a challenge. While bile acids have been implicated in various diseases, their role as biomarkers for sepsis is underexplored. This study aims to identify metabolites associated with sepsis and assess the potential of bile acids for early diagnosis and prognosis of pediatric sepsis. We enrolled 100 participants in the discovery phase and 141 participants in the validation phase. Non-targeted liquid chromatography-mass spectrometry (LC-MS) metabolomics analyses were performed to identify differential metabolites between sepsis patients and healthy controls. Targeted quantitative analysis of 12 plasma bile acids (BA) was conducted to assess their concentrations. Machine learning algorithms, including Recursive Feature Elimination (RFE), Least Absolute Shrinkage and Selection Operator (LASSO), Random Forest (RF), Support Vector Machine-RFE (SVM-RFE), and Gradient Boosting Decision Tree (GBDT), were employed to identify key BAs for sepsis diagnosis. Untargeted metabolomics revealed bile acid pathway dysregulation, validated by targeted quantification showing elevated primary bile acids—cholic acid (CA), glycocholic acid (GCA), taurocholic acid (TCA), glycochenodeoxycholic acid (GCDCA), taurochenodeoxycholic acid (TCDCA)—and taurine-conjugated secondary bile acid TDCA (p<0.05). Conversely, secondary bile acids deoxycholic acid (DCA), glycodeoxycholic acid (GDCA), ursodeoxycholic acid (UDCA), glycoursodeoxycholic acid (GUDCA), and lithocholic acid (LCA) were significantly reduced (p<0.05). Univariate logistic regression identified TCA, TDCA, GCA, TCDCA, GCDCA, and TDCA/DCA as risk factors for sepsis, while LCA, DCA, UDCA, GUDCA, and DCA/CA were protective factors. Five machine learning models identified four bile acid indicators—UDCA, GUDCA, GCA, DCA—as key predictors for sepsis diagnosis, with a combined model area under the curve (AUC) of 0.880. Additionally, DCA/CA and GCDCA were important predictors for septic shock, with risks increasing by 4.5% (OR = 1.045, 95% CI: 1.009–1.081) and 30% (OR = 0.700, 95% CI: 0.526–0.932), respectively. LCA was a risk factor for respiratory failure in sepsis, with an OR of 2.154 (95% CI: 1.022–4.540). Our results highlight the potential of bile acid profiling as a diagnostic and prognostic biomarker for pediatric sepsis. These findings suggest a path toward early intervention, improving patient outcomes by enabling timely detection and treatment.
- 1 December 2025
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 18, 18151-18163
Open AccessPlasma Bile Acid Profiling Reveals Novel Early Diagnostic Biomarkers for Pediatric Sepsis
Sepsis is a life-threatening condition, and early detection remains a challenge. While bile acids have been implicated in various diseases, their role as biomarkers for sepsis is underexplored. This study aims to identify metabolites associated with sepsis and assess the potential of bile acids for early diagnosis and prognosis of pediatric sepsis. We enrolled 100 participants in the discovery phase and 141 participants in the validation phase. Non-targeted liquid chromatography-mass spectrometry (LC-MS) metabolomics analyses were performed to identify differential metabolites between sepsis patients and healthy controls. Targeted quantitative analysis of 12 plasma bile acids (BA) was conducted to assess their concentrations. Machine learning algorithms, including Recursive Feature Elimination (RFE), Least Absolute Shrinkage and Selection Operator (LASSO), Random Forest (RF), Support Vector Machine-RFE (SVM-RFE), and Gradient Boosting Decision Tree (GBDT), were employed to identify key BAs for sepsis diagnosis. Untargeted metabolomics revealed bile acid pathway dysregulation, validated by targeted quantification showing elevated primary bile acids—cholic acid (CA), glycocholic acid (GCA), taurocholic acid (TCA), glycochenodeoxycholic acid (GCDCA), taurochenodeoxycholic acid (TCDCA)—and taurine-conjugated secondary bile acid TDCA (p<0.05). Conversely, secondary bile acids deoxycholic acid (DCA), glycodeoxycholic acid (GDCA), ursodeoxycholic acid (UDCA), glycoursodeoxycholic acid (GUDCA), and lithocholic acid (LCA) were significantly reduced (p<0.05). Univariate logistic regression identified TCA, TDCA, GCA, TCDCA, GCDCA, and TDCA/DCA as risk factors for sepsis, while LCA, DCA, UDCA, GUDCA, and DCA/CA were protective factors. Five machine learning models identified four bile acid indicators—UDCA, GUDCA, GCA, DCA—as key predictors for sepsis diagnosis, with a combined model area under the curve (AUC) of 0.880. Additionally, DCA/CA and GCDCA were important predictors for septic shock, with risks increasing by 4.5% (OR = 1.045, 95% CI: 1.009–1.081) and 30% (OR = 0.700, 95% CI: 0.526–0.932), respectively. LCA was a risk factor for respiratory failure in sepsis, with an OR of 2.154 (95% CI: 1.022–4.540). Our results highlight the potential of bile acid profiling as a diagnostic and prognostic biomarker for pediatric sepsis. These findings suggest a path toward early intervention, improving patient outcomes by enabling timely detection and treatment.
- Open Access
- 26 October 2023
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 14, 1232325
Digging out the biology properties of tRNA-derived small RNA from black hole
An unique subclass of functional non-coding RNAs generated by transfer RNA (tRNA) under stress circumstances is known as tRNA-derived small RNA (tsRNA). tsRNAs can be divided into tRNA halves and tRNA-derived fragments (tRFs) based on the different cleavage sites. Like microRNAs, tsRNAs can attach to Argonaute (AGO) proteins to target downstream mRNA in a base pairing manner, which plays a role in rRNA processing, gene silencing, protein expression and viral infection. Notably, tsRNAs can also directly bind to protein and exhibit functions in transcription, protein modification, gene expression, protein stabilization, and signaling pathways. tsRNAs can control the expression of tumor suppressor genes and participate in the initiation of cancer. It can also mediate the progression of diseases by regulating cell viability, migration ability, inflammatory factor content and autophagy ability. Precision medicine targeting tsRNAs and drug therapy of plant-derived tsRNAs are expected to be used in clinical practice. In addition, liquid biopsy technology based on tsRNAs indicates a new direction for the non-invasive diagnosis of diseases.
- 26 October 2023
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 14, 1232325
Open AccessDigging out the biology properties of tRNA-derived small RNA from black hole
An unique subclass of functional non-coding RNAs generated by transfer RNA (tRNA) under stress circumstances is known as tRNA-derived small RNA (tsRNA). tsRNAs can be divided into tRNA halves and tRNA-derived fragments (tRFs) based on the different cleavage sites. Like microRNAs, tsRNAs can attach to Argonaute (AGO) proteins to target downstream mRNA in a base pairing manner, which plays a role in rRNA processing, gene silencing, protein expression and viral infection. Notably, tsRNAs can also directly bind to protein and exhibit functions in transcription, protein modification, gene expression, protein stabilization, and signaling pathways. tsRNAs can control the expression of tumor suppressor genes and participate in the initiation of cancer. It can also mediate the progression of diseases by regulating cell viability, migration ability, inflammatory factor content and autophagy ability. Precision medicine targeting tsRNAs and drug therapy of plant-derived tsRNAs are expected to be used in clinical practice. In addition, liquid biopsy technology based on tsRNAs indicates a new direction for the non-invasive diagnosis of diseases.
- Open Access
- 1 December 2020
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 6 (12) , 1979-1980
Important Concerns Over SARS-CoV-2 Infection in Children With Cancer
To the Editor We read with great interest the Research Letter by Boulad et al that reports a low morbidity of coronavirus disease 2019 (COVID-19) in pediatric p
- 1 December 2020
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 6 (12) , 1979-1980
Open AccessImportant Concerns Over SARS-CoV-2 Infection in Children With Cancer
To the Editor We read with great interest the Research Letter by Boulad et al that reports a low morbidity of coronavirus disease 2019 (COVID-19) in pediatric p
- Open Access
- 1 December 2020
- Published by American Medical Association (AMA) in JAMA Pediatrics
- Vol. 174 (12) , 1218
Additional Concerns Regarding Children With Coronavirus Disease 2019
To the Editor We read with great interest the study by Castagnoli et al that shows milder symptoms, better prognosis, and less severe conditions in children wit
- 1 December 2020
- Published by American Medical Association (AMA) in JAMA Pediatrics
- Vol. 174 (12) , 1218
Open AccessAdditional Concerns Regarding Children With Coronavirus Disease 2019
To the Editor We read with great interest the study by Castagnoli et al that shows milder symptoms, better prognosis, and less severe conditions in children wit
- 1 March 2013
- Published by Elsevier in Antiviral Research
- Vol. 97 (3) , 369-375
In vitro inhibition of Japanese encephalitis virus replication by capsid-targeted virus inactivation
- 1 March 2013
- Published by Elsevier in Antiviral Research
- Vol. 97 (3) , 369-375
In vitro inhibition of Japanese encephalitis virus replication by capsid-targeted virus inactivation